Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Treatment Show Comments PDF Print E-mail
  
Tuesday, 16 May 2006
  • TCC of the renal pelvis
    • Antegrade nephroscopy and tissue ablation. Appropriate for low grade papillary lesions in the ureter and accessible areas in the renal pelvis. Ablation can be performed with diathermy, cold knife of laser. Role of BCG or mitomycin is incompletely defined.
    • Nephroureterectomy. Standard therapy for large or high grade lesions in the renal pelvis. Laparoscopic approach has gained significant appeal in the past several years. Resection of the renal unit, the entire ureter and a portion of bladder cuff is mandatory for effective therapy.
  • TCC of the ureter
    • Partial ureterectomy and reimplantation. Appropriate for bulky low grade lesions and moderate to high grade lesions in the lower ureter without evidence of other disease foci. Also high risk surgical candidates, a solitary renal unit, and renal insufficiency.
    • Nephroureterectomy. Appropriate for lesions of the upper two thirds of the ureter and full ureter with multifocal disease.
  • Chemotherapy
    • Large series of BCG or mitomycin treated lesions not available
    • Low grade solitary lesions respond well. Multiple recurrences in initial multifocal disease
    • MVAC or Cis platinum plus Gemcitabine combinations acceptable for higher stage lesions. Taxol plus Carboplatinum combination good for patients with renal insufficiency

References

  • Carroll PC, Dixon CM. Surgical anatomy of the male and female urethra. Urol Clin North Am 19:339-346, 1992.
  • Cataluna WJ: Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous vein: Technique and preliminary results. J Urol 140:836, 1988.
  • deKernion JB, Abi-Aad AS: Controversies in ilioinguinal lymphadenectomy for cancer of the penis. Urol Clin North Am 19:319-324, 1992.
  • Forman JD, Lichter AS: The role of radiation therapy in the management of carcinoma of the male and female urethra. Urol Clin North Am 19:383-390, 1992.
  • Gerbaulet A, Lambin P: Radiation therapy of cancer of the penis: Indications, advantages, and pitfalls. Urol Clin North Am 19:325-332, 1992.
  • Johnson DE, Ames FC: Groin Dissection. Chicago, Yearbook Medical Publishers, 1985.
  • Lowe FC: Squamous cell carcinoma of the scrotum. J Urol 130:423, 1983. Russo P, Gaudin P: Carcinoma of the penis: Diagnosis and staging. Cont Urol 4:12-31, 2000.
  • Schellhammer PF, Jordan GH, Schlossberg SM: Tumors of the penis. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, eds. Campbell's Urology, 6th ed. Philadelphia, Saunders, 1992, pp 1264-1298.
  • Skinner EC, Skinner DG: Management of carcinoma of the female urethra. In: Skinner DG, Lieskovsky G, eds. Diagnosis and Management of Genitourinary Cancer. Philadelphia, Saunders, 1988, pp 490-497.

Reader Comments
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2008-08-08 18:31:58
I appreciate any and all information related to this topic. I impatiently await the day something is discovered that will help me deal with my persistant pain.
Consultant Urologist
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2007-10-21 01:50:40
Very good & informative.
MS. C.
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2007-02-03 23:05:05
WHEN I WAS DIAGNOSED WITH I.C. 10 YEARS AGO I WAS GIVEN TEN AND A HALF MONTHS OF WEEKLY DMSO (RIMSO) INSTILLATIONS. I NOTICED MY EYESIGHT WAS BEING ADVERSLY AFFECTED DURING THIS TIME. AFTER MUCH RESEARCH THRU THE VETERINARY DEPT. AT UGA I WAS INFORMED THAT DMSO IS A SOLVENT THAT MAY ATTACK SOFT TISSUE AND THIS IN MY CASE IT WAS MY EYESIGHT. MY VISION WENT FROM 20/20 TO 20/95. I REALIZED AFTER MY RESEARCH THAT THESE TREATMENTS SHOULD HAVE BEEN DONE FOR NO MORE THAN 6 WEEKS BUT I WOULD LIKE TO ADVISE OTHER I.C. PATIENTS TO TAKE CAUTION AND DISCUSS THE POSSIBLE SIDE EFFECTS WITH THEIR UROLOGIST BEFORE PROCEEDING.

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 

Bookmark and Share

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts


Featured Conference

Working with Industry

Case Studies
Sponsorship Opportunities

Renal Cancer
Sponsored By